Trexquant Investment’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.4M	Buy	61,760 +35,019	+131%	+$11.9M	0.15%	148
2025 Q4	$10.6M	Buy	26,741 +14,345	+116%	+$6.35M	0.09%	291
2025 Q3	$5.65M	Sell	12,396 -8,147	-40%	-$3.32M	0.06%	504
2025 Q2	$6.7M	Buy	+20,543	New	+$5.68M	0.08%	413
2025 Q1	–	Sell	-44,024	Closed	-$10.4M	–	1525
2024 Q4	$10.4M	Sell	44,024 -46,719	-51%	-$12.3M	0.12%	251
2024 Q3	$25M	Buy	90,743 +52,880	+140%	+$13.8M	0.32%	54
2024 Q2	$9.2M	Sell	37,863 -59,112	-61%	-$9.33M	0.14%	211
2024 Q1	$14.5M	Buy	96,975 +45,578	+89%	+$7.6M	0.29%	54
2023 Q4	$9.84M	Buy	51,397 +40,376	+366%	+$6.88M	0.22%	109
2023 Q3	$1.95M	Buy	+11,021	New	+$2.1M	0.05%	496
2023 Q1	–	Sell	-43,673	Closed	-$10.4M	–	1409
2022 Q4	$10.4M	Buy	43,673 +561	+1%	+$120K	0.29%	81
2022 Q3	$8.63M	Buy	+43,112	New	+$8.22M	0.3%	73
2022 Q2	–	Sell	-21,496	Closed	-$3.51M	–	1487
2022 Q1	$3.51M	Buy	+21,496	New	+$3.27M	0.16%	152
2021 Q1	–	Sell	-6,393	Closed	-$831K	–	1092
2020 Q4	$831K	Buy	+6,393	New	+$854K	0.09%	301
2020 Q2	–	Sell	-16,471	Closed	-$1.79M	–	1146
2020 Q1	$1.79M	Buy	16,471 +10,522	+177%	+$1.21M	0.13%	238
2019 Q4	$685K	Buy	5,949 +214	+4%	+$21.3K	0.04%	469
2019 Q3	$461K	Sell	5,735 -8,858	-61%	-$701K	0.04%	472
2019 Q2	$1.06M	Buy	14,593 +4,513	+45%	+$346K	0.1%	297
2019 Q1	$942K	Buy	+10,080	New	+$843K	0.07%	415
2018 Q1	–	Sell	-3,021	Closed	-$384K	–	1043
2017 Q4	$384K	Buy	+3,021	New	+$380K	0.04%	625
2015 Q4	–	Sell	-27,859	Closed	-$2.24M	–	985
2015 Q3	$2.24M	Buy	+27,859	New	+$3.1M	0.19%	126